PLT Production

Overview of Thrombopoiesis

  • Definition: The process of platelet production, development, and maturation, primarily occurring in the bone marrow
  • Purpose: To maintain an adequate number of platelets in the circulation to ensure proper hemostasis (blood clotting) and prevent excessive bleeding
  • Key Cell: Megakaryocyte (MK) - the large, multinucleated cell responsible for producing platelets
  • Regulation: Primarily regulated by thrombopoietin (TPO), but other factors also play a role

Hematopoietic Stem Cells (HSCs) and Megakaryocyte Development

  • Hematopoietic Stem Cells (HSCs):
    • Self-renewing cells that can differentiate into all blood cell lineages
    • Reside in the bone marrow
  • Common Myeloid Progenitor (CMP):
    • Gives rise to granulocytes, monocytes, macrophages, megakaryocytes, and erythrocytes
  • Megakaryocyte-Erythroid Progenitor (MEP):
    • A progenitor cell that can differentiate into either megakaryocytes or erythrocytes
  • Megakaryoblast:
    • Earliest identifiable megakaryocyte precursor
    • Large cell with a single, round nucleus
    • Cytoplasm is basophilic and lacks granules
  • Promegakaryocyte:
    • Larger than megakaryoblast
    • Nucleus undergoes endomitosis (DNA replication without cell division), resulting in a multilobed or polyploid nucleus
    • Cytoplasm becomes more abundant and contains some granules
  • Megakaryocyte (MK):
    • The largest cell in the bone marrow
    • Large, multilobed nucleus with condensed chromatin
    • Abundant cytoplasm filled with granules (alpha granules and dense granules)
    • Responsible for platelet production
  • Platelet Production:
    • Megakaryocytes extend long, branching cytoplasmic processes called proplatelets into the bone marrow sinusoids (blood vessels)
    • Proplatelets fragment into individual platelets, which are then released into the circulation

Thrombopoietin (TPO) and Regulation of Thrombopoiesis

  • Thrombopoietin (TPO):
    • Primary regulator of megakaryopoiesis and thrombopoiesis
    • Produced mainly by the liver, with smaller amounts produced by the kidney and bone marrow stromal cells
    • Binds to the MPL receptor (also known as c-MPL) on hematopoietic stem cells, megakaryocyte progenitors, and platelets
  • Mechanisms of Action of TPO:
    • Stimulates the proliferation and differentiation of megakaryocyte progenitors
    • Promotes megakaryocyte maturation and polyploidization (endomitosis)
    • Increases platelet production by megakaryocytes
    • Prevents apoptosis (programmed cell death) of megakaryocytes
  • Regulation of TPO Levels:
    • TPO production is relatively constant
    • Platelets and megakaryocytes bind and internalize TPO, reducing the amount of TPO available to stimulate further platelet production
    • In thrombocytopenia (low platelet count), there are fewer platelets to bind TPO, so TPO levels increase, stimulating megakaryopoiesis
    • In thrombocytosis (high platelet count), there are more platelets to bind TPO, so TPO levels decrease, suppressing megakaryopoiesis

Other Factors Influencing Thrombopoiesis

  • Cytokines:
    • Interleukin-6 (IL-6): Stimulates megakaryocyte proliferation and maturation
    • Interleukin-11 (IL-11): Promotes megakaryocyte maturation and platelet production
    • Stem Cell Factor (SCF): Supports the survival and proliferation of HSCs and early progenitors
  • Growth Factors:
    • Thrombopoietin (TPO) is the main driver!
  • Transcription Factors:
    • GATA-1: Essential for megakaryocyte development
    • FLI1: Involved in megakaryocyte differentiation and function
  • Bone Marrow Microenvironment:
    • Stromal cells in the bone marrow provide a supportive niche for megakaryocytes
    • Extracellular matrix components, adhesion molecules, and growth factors influence megakaryopoiesis

Platelet Structure and Function

  • Platelets (Thrombocytes):
    • Small, anucleate cell fragments produced by megakaryocytes
    • Essential for hemostasis (blood clotting)
    • Normal Platelet Count: 150-450 x 10^9/L
  • Structure:
    • Plasma membrane: Contains receptors for adhesion, activation, and aggregation
    • Glycocalyx: Outer coating containing glycoproteins that mediate adhesion to subendothelial matrix and other platelets
    • Cytoplasm:
      • Granules:
        • Alpha granules: Contain clotting factors (e.g., fibrinogen, von Willebrand factor), growth factors, and adhesion molecules
        • Dense granules (δ-granules): Contain ADP, ATP, serotonin, and calcium
      • Open Canalicular System (OCS): System of channels that connect the platelet interior to the external environment
      • Dense Tubular System (DTS): Storage site for calcium ions
      • Microtubules and Actin Filaments: Provide structural support and facilitate shape change and movement
  • Functions:
    • Primary Hemostasis: Formation of the platelet plug
    • Secondary Hemostasis: Contributing to the coagulation cascade and fibrin clot formation
    • Vessel Repair: Releasing growth factors that promote wound healing and angiogenesis
    • Inflammation: Releasing inflammatory mediators

Disorders of Thrombopoiesis

  • Thrombocytopenia: Decreased platelet count (<150 x 10^9/L)
    • Decreased Production:
      • Aplastic anemia
      • Myelodysplastic syndromes (MDS)
      • Infections
      • Medications
      • Alcohol abuse
    • Increased Destruction:
      • Immune thrombocytopenic purpura (ITP)
      • Thrombotic thrombocytopenic purpura (TTP)
      • Heparin-induced thrombocytopenia (HIT)
      • Disseminated intravascular coagulation (DIC)
    • Sequestration:
      • Splenomegaly
  • Thrombocytosis: Increased platelet count (>450 x 10^9/L)
    • Reactive Thrombocytosis:
      • Occurs in response to another condition (e.g., infection, inflammation, iron deficiency, splenectomy)
      • Platelet count is usually mildly elevated and transient
    • Essential Thrombocythemia (ET):
      • A myeloproliferative neoplasm characterized by sustained thrombocytosis and increased risk of thrombosis and bleeding
      • Associated with mutations in JAK2, CALR, or MPL

Laboratory Evaluation of Thrombopoiesis

  • Complete Blood Count (CBC):
    • Platelet Count: Measures the number of platelets in the blood
  • Peripheral Blood Smear Examination:
    • Platelet Estimate: Evaluates the number of platelets on the smear and confirms the automated platelet count
    • Platelet Morphology: Identifies abnormal platelet morphology (e.g., giant platelets, hypogranular platelets)
  • Bone Marrow Aspiration and Biopsy:
    • Megakaryocyte Number and Morphology: Assesses the number and morphology of megakaryocytes in the bone marrow
  • Flow Cytometry:
    • To identify cell surface markers on megakaryocytes
  • Molecular Testing:
    • To detect mutations in genes involved in megakaryopoiesis (e.g., JAK2, CALR, MPL)
  • Platelet Function Tests:
    • To evaluate platelet adhesion, aggregation, and secretion
    • Platelet aggregation studies
    • Platelet function analyzer (PFA-100)

Key Terms

  • Thrombopoiesis: Platelet production
  • Megakaryocyte: Large, multinucleated cell responsible for producing platelets
  • Thrombopoietin (TPO): Hormone that regulates megakaryopoiesis and thrombopoiesis
  • Platelet (Thrombocyte): Small, anucleate cell fragment involved in hemostasis
  • Thrombocytopenia: Decreased platelet count
  • Thrombocytosis: Increased platelet count
  • Essential Thrombocythemia (ET): Myeloproliferative neoplasm with sustained thrombocytosis
  • Endomitosis: DNA replication without cell division
  • Proplatelets: Cytoplasmic extensions of megakaryocytes that fragment into platelets
  • Platelet Aggregation: The clumping together of platelets to form a platelet plug
  • Mean Platelet Volume (MPV): The average size of platelets